C Gazzaruso

Summary

Affiliation: Vallo della Lucania
Country: Italy

Publications

  1. ncbi Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Pavia, Italy
    Am J Cardiol 97:236-9. 2006
  2. ncbi Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
    Circulation 110:22-6. 2004
  3. ncbi Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors
    Carmine Gazzaruso
    Cardio Metabolic Unit and the Centre for Applied Clinical Research Ce R C A Clinical Institute Beato Matteo, Hospital Group San Donato, Vigevano, Italy
    J Am Coll Cardiol 51:2040-4. 2008
  4. ncbi Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Via Aselli 5, 27100 Pavia, Italy
    Expert Rev Cardiovasc Ther 4:173-80. 2006
  5. ncbi Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients
    C Gazzaruso
    Interdepartmental Center for Research in Molecular Medicine CIRMC, University of Pavia and IRCCS Maugeri Foundation Hospital Pavia, Pavia, Italy
    Int J Impot Res 18:311-5. 2006
  6. ncbi [Current opinions on the relationships between atherosclerosis, type 2 diabetes mellitus and erectile dysfunction]
    Carmine Gazzaruso
    U O Medicina Interna, Presidio Ospedaliero di Sarnico, I R C C S Fondazione Salvatore Maugeri, Pavia
    Recenti Prog Med 96:155-8. 2005
  7. ncbi Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
    C Gazzaruso
    IRCCS Maugeri Foundation Hospital, Section of Internal Medicine, Diabetes Centre, Pavia, Italy
    Diabet Med 18:589-94. 2001
  8. ncbi Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients
    C Gazzaruso
    IRCCS Maugeri Foundation Hospital Scientific Institue of Pavia, Italy
    Int J Cardiol 108:354-8. 2006
  9. ncbi Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease
    C Falcone
    Department of Cardiology, IRCCS San Matteo Hospital, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy
    Int J Cardiol 90:219-27. 2003
  10. ncbi Role of endogenous androgens on carotid atherosclerosis in non-obese postmenopausal women
    T Montalcini
    Department of Medicina Sperimentale e Clinica G Salvatore, University of Catanzaro Magna Graecia, U O Medicina Interna, Viale Europa, Germaneto, 88100 Catanzaro, Italy
    Nutr Metab Cardiovasc Dis 17:705-11. 2007

Collaborators

Detail Information

Publications23

  1. ncbi Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Pavia, Italy
    Am J Cardiol 97:236-9. 2006
    ..Other studies are needed to establish whether metabolic syndrome and HOMA are reliable markers to identify diabetic patients for additional screening for silent CAD...
  2. ncbi Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
    Circulation 110:22-6. 2004
    ..In diabetic patients, CAD is often silent. Among diabetic patients with silent CAD, the prevalence of ED has never been evaluated. We investigated whether ED is associated with asymptomatic CAD in type 2 diabetic patients...
  3. ncbi Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors
    Carmine Gazzaruso
    Cardio Metabolic Unit and the Centre for Applied Clinical Research Ce R C A Clinical Institute Beato Matteo, Hospital Group San Donato, Vigevano, Italy
    J Am Coll Cardiol 51:2040-4. 2008
    ....
  4. ncbi Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Via Aselli 5, 27100 Pavia, Italy
    Expert Rev Cardiovasc Ther 4:173-80. 2006
    ..Finally, recent guidelines on the treatment of erectile dysfunction with phosphodiesterase-5 inhibitors in diabetic patients with and without coronary artery disease have been reported and discussed...
  5. ncbi Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients
    C Gazzaruso
    Interdepartmental Center for Research in Molecular Medicine CIRMC, University of Pavia and IRCCS Maugeri Foundation Hospital Pavia, Pavia, Italy
    Int J Impot Res 18:311-5. 2006
    ..However, no correlation was found between the extent of angiographic CAD and the presence or the severity of ED...
  6. ncbi [Current opinions on the relationships between atherosclerosis, type 2 diabetes mellitus and erectile dysfunction]
    Carmine Gazzaruso
    U O Medicina Interna, Presidio Ospedaliero di Sarnico, I R C C S Fondazione Salvatore Maugeri, Pavia
    Recenti Prog Med 96:155-8. 2005
    ..In particular, erectile dysfunction may be used as a predictor of silent or early athero-thrombotic diseases, especially in diabetic patients...
  7. ncbi Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
    C Gazzaruso
    IRCCS Maugeri Foundation Hospital, Section of Internal Medicine, Diabetes Centre, Pavia, Italy
    Diabet Med 18:589-94. 2001
    ..We also examined whether there are differences in the distributions of Lp(a) levels and apo(a) phenotypes between CAD patients with and without diabetes...
  8. ncbi Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients
    C Gazzaruso
    IRCCS Maugeri Foundation Hospital Scientific Institue of Pavia, Italy
    Int J Cardiol 108:354-8. 2006
    ..The purpose of the present study was to analyse the association of the degree of coronary atherosclerosis with Lp(a) levels and apo(a) polymorphism in a large group of type 2 diabetic patients...
  9. ncbi Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease
    C Falcone
    Department of Cardiology, IRCCS San Matteo Hospital, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy
    Int J Cardiol 90:219-27. 2003
    ..The aim of the present study was to evaluate the prevalence of silent ischemia in diabetic and nondiabetic patients with assessed CAD...
  10. ncbi Role of endogenous androgens on carotid atherosclerosis in non-obese postmenopausal women
    T Montalcini
    Department of Medicina Sperimentale e Clinica G Salvatore, University of Catanzaro Magna Graecia, U O Medicina Interna, Viale Europa, Germaneto, 88100 Catanzaro, Italy
    Nutr Metab Cardiovasc Dis 17:705-11. 2007
    ..In particular androgens seem to have a protective role on atherosclerosis. The present study was performed to assess the role of endogenous sex hormones on carotid atherosclerosis in postmenopausal women...
  11. ncbi Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome
    Carmine Gazzaruso
    Internal Medicine Unit, Cardiovascular Prevention Clinic ASTRA, IRCCS Maugeri Foundation Hospital, Scientific Institute of Pavia, Italy
    J Hypertens 21:1377-82. 2003
    ....
  12. ncbi Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism
    Carmine Gazzaruso
    Internal Medicine Unit, Diabetes Center, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
    Diabetes Care 25:1418-24. 2002
    ..We investigated the association of Lp(a) and apo(a) polymorphism with angiographically documented asymptomatic CAD in type 2 diabetic patients without evident complications...
  13. ncbi Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients
    Carmine Gazzaruso
    Diabetes Center, Internal Medicine Unit, Department of Internal Medicine and Medical Therapeutics, IRCCS Maugeri Foundation Hospital, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy
    J Diabetes Complications 17:135-40. 2003
    ..On the contrary, Lp(a) and apo(a) polymorphisms do not appear to be reliable markers of restenosis in patients with Type 2 diabetes mellitus...
  14. ncbi Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Via Ferrata 8, 27100 Pavia, Italy
    Obes Surg 12:841-5. 2002
    ..The aim of the present longitudinal study was to evaluate the relationship between weight loss and changes in insulin-resistance and in the prevalence of the metabolic syndrome 1-year after SAGB implantation...
  15. ncbi Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy
    Int J Cardiol 87:91-8. 2003
    ..The aim of the present prospective study was to evaluate whether lipoprotein(a) levels and apolipoprotein(a) phenotypes are predictors of restenosis after elective stent implantation in patients with de novo lesions of coronary arteries...
  16. ncbi Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease
    Piercarlo Minoretti
    Interdepartmental Center for Research in Molecular Medicine CIRMC, University of Pavia, Viale Taramelli 24, I 27100 Pavia, Italy
    Neurosci Lett 391:147-9. 2006
    ..37 (95% CI: 0.20-0.69, P=0.002). Our data further support a role for innate immunity in neurodegeneration and give the first evidence that the TLR4 Asp299Gly variant may be protective toward the development of LOAD...
  17. ncbi Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus
    Sebastiano B Solerte
    Department of Internal Medicine, Geriatric Clinic, University of Pavia, Pavia, Italy
    Am J Cardiol 93:23A-29A. 2004
    ..We suggest that increased amino acid availability for skeletal muscle function and strength could ameliorate metabolic control and insulin sensitivity in elderly patients with poorly controlled type 2 diabetes...
  18. ncbi Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients
    Riccardo Bellazzi
    Dipartimento di Informatica e Sistemistica DIS, Universita di Pavia, Via Ferrata 1, 27100 Pavia, Italy
    Diabetes Technol Ther 5:621-9. 2003
    ..The M2DM system allows for the implementation of an easy-to-use, user-tailored telemedicine system for diabetes management. The first clinical results are encouraging and seem to substantiate the hypothesis of its clinical effectiveness...
  19. ncbi Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus
    Sebastiano B Solerte
    Geriatric Clinic, Department of Internal Medicine, University of Pavia, Pavia, Italy
    Am J Cardiol 101:82E-88E. 2008
    ..This effect was consistent during the long-term observation period of 60 weeks and was also present after the crossover from AAs to placebo...
  20. ncbi Management of patients with diabetes through information technology: tools for monitoring and control of the patients' metabolic behavior
    Riccardo Bellazzi
    Dipartimento di Informatica e Sistemistica, Universita di Pavia, Italy
    Diabetes Technol Ther 6:567-78. 2004
    ....
  21. ncbi High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk
    Raffaele Bruno
    J Acquir Immune Defic Syndr 31:363-5. 2002
  22. ncbi Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women
    Tiziana Montalcini
    Department of Medicina Sperimentale e Clinica G Salvatore, University of Catanzaro Magna Graecia, Viale Europa Germaneto, Catanzaro, Italy
    Diabetes Res Clin Pract 76:378-82. 2007
    ..The purpose of this study was to investigate whether the subclinical carotid atherosclerosis prevalence is different in obese postmenopausal women with and without the metabolic syndrome...
  23. ncbi Prevalence of metabolic syndrome among HIV patients
    Carmine Gazzaruso
    Diabetes Care 25:1253-4. 2002